Non Bleeding Patients With ThrombocytopeniaNCT07915284
Platelet Transfusion Thresholds in Non-Bleeding Patients
An observational study of Non Bleeding Patients With Thrombocytopenia, run by Sohag University at 1 site in Egypt.
Trial summary
This is a study of platelet transfusion thresholds in patients with thrombocytopenia without bleeding and benifits of transfusion in those critically ill patients to prevent bleeding Read more about this study
- Who is it for?
- Ages 1 month to 18 years
- Conditions the study is for
- Non Bleeding Patients With Thrombocytopenia
- What is being tested?
- Platlet transfusion
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 30 Oct 2026to 15 Sep 2027
- How long will I take part?
- 10 Days
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 month to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Pediatric patient admitted at PICU from age of day 1- to 18-year-old.
Who may be able to join
- Duration of stay in PICU [more than 24 hours].
Who cannot join
- 1-Any patient with missing data or refusal to be in the study. 2-Patients with active bleeding. 3- Patients known to have chronic platelet disorder. 4- Patients on heparin, any anticoagulant or antiplatelet drugs.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site
Sohag University Hospital
Sohag
Rehab Mohammed Abdellatif, Pediatric residant, 01127021954, rebom66@gmail.com
About this study
Official title: Platelet Transfusion Thresholds and Clinical Outcomes in Non-Bleeding Patients Admitted to Pediatric Intensive Care Unit at Sohag University Hospitals
This is a study of platelet transfusion thresholds in patients with thrombocytopenia without bleeding and benifits of transfusion in those critically ill patients to prevent bleeding
Read the detailed description
This is a Prospective cohort hospital-based study To determine the threashold and outcome of platelet transfusion in non bleeding critically ill children in PICU
- Being tested
- Platlet transfusion
- Keywords
- Platelet transfusion threshold, Non-Bleeding patients, PICU
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Platlet transfusionOther
Platelt transfusion in Non Bleeding patients admitted to pediatric intensive care unit
| Study group | Role | What they receive |
|---|---|---|
| Children from 1m to 18 year | Platlet transfusion thresholds and clinical outcomes in Non Bleeding patients admitted to PICU Receives: Other: Platlet transfusion |
What is being measured
The primary outcome is the main question the study is designed to answer.
Platelet transfusion .
Measured: 1 year
Secondary outcomes (1)
Bleeding.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Nov 2026
- Study start30 Oct 2026 (estimated)
- Primary completion10 Sep 2027 (estimated)
- Study completion15 Sep 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Non Bleeding Patients With ThrombocytopeniaStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
- Target duration
- 10 Days
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rehab Mohamed Abdellatif, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07915284
- Sponsor's protocol ID
- Soh-Med-26-9-6MS
- Status last verified
- Oct 2026
- First submitted
- 18 Oct 2026
- Last updated
- 4 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: individuals participant data will not be shared due to privacy protection policies at Sohag university Hospital
Publications
https://med.sohag-univ.edu.eg/main/
Study at a glance
From the registry record, last updated by the sponsor on 4 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Platelet Transfusion Thresholds and Clinical Outcomes in Non-Bleeding Patients Admitted to Pediatric Intensive Care Unit at Sohag University Hospitals
- ClinicalTrials.gov ID
- NCT07915284
- Acronym / sponsor ID
- Soh-Med-26-9-6MS
- Keywords
- Platelet transfusion threshold, Non-Bleeding patients, PICU
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 30 Oct 2026 (estimated)
- Primary completion
- 10 Sep 2027 (estimated)
- Study completion
- 15 Sep 2027 (estimated)
- First posted
- 4 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a study of platelet transfusion thresholds in patients with thrombocytopenia without bleeding and benifits of transfusion in those critically ill patients to prevent bleeding
Detailed description
This is a Prospective cohort hospital-based study To determine the threashold and outcome of platelet transfusion in non bleeding critically ill children in PICU
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 10 Days
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Children from 1m to 18 year | – | Other: Platlet transfusionPlatlet transfusion thresholds and clinical outcomes in Non Bleeding patients admitted to PICU |
Who may qualify
- Ages
- 1 month to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Pediatric patient admitted at PICU from age of day 1- to 18-year-old.
Key inclusion criteria (1 listed)
- Duration of stay in PICU [more than 24 hours].
Key exclusion criteria (1 listed)
- 1-Any patient with missing data or refusal to be in the study. 2-Patients with active bleeding. 3- Patients known to have chronic platelet disorder. 4- Patients on heparin, any anticoagulant or antiplatelet drugs.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Platlet transfusionPlatelt transfusion in Non Bleeding patients admitted to pediatric intensive care unit | Other | Children from 1m to 18 year |
Primary outcome
Platelet transfusion .
Time frame: 1 year
1 secondary outcome
Bleeding.
Time frame: 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Nov 2026.
- Results publicationhttps://med.sohag-univ.edu.eg/main/
- Individual participant dataSharing planned: No. individuals participant data will not be shared due to privacy protection policies at Sohag university Hospital
Related trials for Non Bleeding Patients With Thrombocytopenia
Recruiting
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Non Bleeding Patients With Thrombocytopenia, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 4 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Rehab mohammed abdellatif ali (+201127021954, rebom66@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Platelet transfusion . (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07915284, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2026.